Progress on mTOR in eye diseases

Journal Title: Eye Science (Yanke Xuebao) - Year 2024, Vol 39, Issue 1

Abstract

Mammalian target protein of rapamycin (mTOR) is a protein kinase that primarily involves in the regulation of nutrient levels and growth metabolism in vivo. mTOR serves as a crucial target for cancer, aging, and other metabolic related pathological diseases, participating in various biological processes such as proliferation, transdifferentiation, and autophagy. The eye is considered an area with immune privilege, as the vascular system affects vision and is located outside the central light path. Many areas in the eye have mechanisms for transporting immune cells to the affected areas related to developmental, damaged, or aging. Although the immune response is primarily aimed at repairing or protecting itself, immune cells may secrete some cytokines, leading to inflammation or fibrosis, which in turn can damage vision. Results from studies have confirmed that mTOR is closely related to pterygium, age-related macular degeneration (AMD), glaucoma, cataract, diabetic retinopathy (DR), eye tumors and other eye diseases. Currently, mTOR inhibitors are widely used as immunosuppressants and approved for cancer treatment; however, there are few reports on the use of mTOR inhibitors for eye diseases. Therefore, in the article it provides a brief overview of the role, regulatory mechanisms, and drug treatment of the mTOR signaling pathway in related ophthalmic diseases, providing ideas for the pathological mechanisms and treatment of related ophthalmic diseases, in order to carry out more in-depth research in the future.

Authors and Affiliations

Yun HUA, Xinrong ZHAO

Keywords

Related Articles

Design and implementation of the LRC stepwise collaborative learning model in ophthalmology training

[Objective:] To introduce the LRC Stepwise Collaborative Learning Model, a novel teaching approach designed to improve clinical thinking skills in ophthalmology training. [Methods:] From July 2023 to December 2024, 26 op...

Operation procedure of intense pulsed light for meibomian gland dysfunction

Meibomian gland dysfunction is a chronic diffuse meibomian gland disease that can cause eye discomfort such as redness, dryness, and foreign body sensation in patients, and influence their eye health and quality of life....

Advantages and disadvantages of real-time face to face online teaching in medical education and its influence on ocular surface diseases

[Objective:] To analyze the advantages and disadvantages of real-time face-to-face online teaching (taking “Tencent Conference” teaching as an example) in medical education and its correlation with ocular surface disease...

Effect evaluation of EYESi simulator combined with Wet-lab in cataract surgery training

[Objective:] To compare the effects and distinctions among three methods of phacoemulsification training: EYESi simulator (Dry-lab), Wet-lab, and a combined approach, in order to find out more scientific and efficient te...

Correlation between transaldolase and choroidal neovascularization and its mechanism in rat models

[Objective:] To observe the expression of transaldolase (TAL) in choroidal neovascularization (CNV) induced by krypton laser in BN rats and investigate its possible mechanism. [Methods:] Twenty rats in two groups were gi...

Download PDF file
  • EP ID EP764715
  • DOI 10.12419/2312260005
  • Views 21
  • Downloads 0

How To Cite

Yun HUA, Xinrong ZHAO (2024). Progress on mTOR in eye diseases. Eye Science (Yanke Xuebao), 39(1), -. https://europub.co.uk/articles/-A-764715